Skip to content

Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief

Testing the Efficacy of a Vibrating, Cold Device for Pediatric IV Cannulation Pain Relief in the Emergency Department

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01394250
Enrollment
240
Registered
2011-07-14
Start date
2011-06-30
Completion date
2013-09-30
Last updated
2016-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Anxiety

Keywords

Pain, Anxiety, IV Cannulation, Topical Lidocaine, Buzzy, Face, Legs, Activity, Crying, Consolability (FLACC) scale, Faces Pain Scale Revised (FPS-R), Child Rating of Anxiety Scale

Brief summary

The purpose of this study is to test the effectiveness of Buzzy®, a battery-powered reusable device that provides cold and vibration, in reducing the pain associated with intravenous (IV) cannulation. The investigators will investigate if Buzzy® is as effective as topical lidocaine cream in reducing the pain associated with IV cannulation.

Detailed description

Intravenous (IV) cannulation is a significant source of pediatric pain and distress. Accumulating evidence has demonstrated that pain from IV cannulation is a significant source of pediatric pain and distress with effects far more reaching than the presenting event. When describing worse pain experiences in hospitalized children, IV cannulation pain was found to be second only to pain related to the subject's underlying disease. Practitioners recognize the need to mitigate or decrease pediatric IV cannulation pain and distress in emergency department patients, yet often do not provide the relief measures that are available. The use of topical lidocaine cream has some barriers, including the need to predict the need for the IV, the 30 minute administration time, difficulty in applying and maintaining the cream, the need for a physician's order and nursing to override in the Pyxis machine in order to obtain the medication in a timely manner. Buzzy® provides a potential alternative to treating pediatric IV cannulation pain in the emergency department (ED), as cold and vibration are quick-acting options for pain relief. If Buzzy® is demonstrated to be as effective or more effective for reducing the pain of IV cannulation it would be an inexpensive and rapid way to provide pain control in accordance to the American Academy of Pediatrics (AAP) and American Pain Society recommendations. The device's actions are based on the Gate Control Theory, whereby cold and vibratory stimulation stimulate large fiber and inhibitory neurons to interrupt nociception. The benefits of Buzzy® include a low cost of $34.99 per reusable device, which could also provide a significant cost savings over the use of single tubes of topical lidocaine cream at a cost of $4.62-12.00 per tube with one or more tubes needed for each patient. Buzzy® does not require a medical order, but must be cleaned according to institution standards and is supplied with either a reusable cold pack or single use cold packs as desired. The commonly voiced concern related to the application of cold causing vasoconstriction has not been borne out in prior studies of Buzzy®. Self-report of pain is the gold standard in evaluating pediatric pain. For this study we will use the Faces Pain Scale-Revised (FPS-R) for rating self-reported pain in children ages 4-18 years. The FPS-R has been validated and frequently used in pediatric pain studies. The FPS-R consists of 6 cartoon faces that range from a neutral expression (no pain) to one of very much pain. Using the same faces, children will be asked how much the procedure hurt from no hurt to very much hurt. Self-reporting of pain is the primary source of data and a secondary measure of data will be an observational pain scale, the face, legs, activity, cry, consolability (FLACC) scale. Because anxiety has proven to affect pain ratings, we will also evaluate anxiety using Child Rating of Anxiety Scale, a visual semantic scale in the form of a thermometer for rating anxiety. All subjects in this study will develop and implement a coping plan with a Child Life Specialist, including preparation, distraction, and deep breathing. This is standard of care in our ED and applied whenever possible for IV placement procedures. Child Life Specialists prepare subjects and families prior to medical procedures to decrease anxiety and increase understanding. Psychological preparation is aimed to increase a subject and family's control over a situation or procedure. While decreasing anxiety and increasing control, the child can move past the event with a sense of mastery and a low level of distress. Preparation close to the event is important for younger subjects, whereas preparation for older subjects is more beneficial when initiated earlier. The effectiveness of distraction in needle related procedures is well documented in the literature. Distraction involves a supportive care giver (if present) as well as a Certified Child Life Specialist; all attempts are made to focus of child away from the pain of the procedure and when possible the child is permitted to hold the objects and manipulate them prior to the procedure to enhance the utilization of a coping plan.

Interventions

DEVICEBuzzy

Cold, Vibrational Device

DRUGTopical Lidocaine 4% Cream

Applied to anticipated IV site at least 30 minutes prior to cannulation.

Sponsors

Children's Hospital of Philadelphia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject is aged 4 to 18 years of age * Subjects will be having a peripheral IV line placed at the discretion of the treating physician for usual care of presenting complaints. * Physician in charge of the subject is willing to wait the 30 minutes needed for the study preparation * Subject/caregiver understands English * Parent or legal guardian has signed Institutional Review Board (IRB) approved informed consent and subject (if age 7 years or older) has given assent

Exclusion criteria

* Subject is critically ill with a triage category of 1 * Subject has a condition that precludes the use of the self-report pain scale * Subject has an abrasion, infection or break in skin in the area where Buzzy® would be placed * Nerve damage is present in the extremity for planned IV placement

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Faces Pain Scale Revised (FPS-R) at 30 Minutes After IV CannulationBaseline and 30 minutesThe Faces Pain Scale Revised (FPS-R) is numerical self-report measure of pain intensity developed for children to score the sensation of pain from 0-10. Pictures of 6 cartoon faces ranging from neutral expression of no pain (0) to very much pain (10).

Secondary

MeasureTime frameDescription
Comparison of the Face, Legs, Activity, Cry, Consolability Scale (FLACC) Score Immediately After IV Cannulation Between GroupsUp to 5 minutes after IV CannulationThe Face, Legs, Activity, Cry, Consolability scale or FLACC scale is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria, which are each assigned a score of 0, 1 or 2. The FLACC score was completed immediately after IV cannulation by a member of the clinical care team who was not part of the study. During initial trial design, the goal was to collect FLACC score pre and post cannulation; however, it was decided prior to enrollment that FLACC score would not be collected pre cannulation, only post.

Countries

United States

Participant flow

Recruitment details

Potential subjects were identified in the Emergency Department (ED) from 2011-2014. When ED nurse anticipated intravenous (IV) placement, a member of the study team was contacted to screen for study eligibility.

Pre-assignment details

A total of 315 subjets signed informed consent forms. Of these 47 subjects were excluded prior to initiation of study procedures. Reasons included parent/child withdrawal of consent, change in clinical treatment plan including the decision to not place an IV for clinical reasons (study exclusion).

Participants by arm

ArmCount
Buzzy®
Buzzy® device was applied prior to intravenous cannulation.
114
Topical Lidocaine 4% Cream
Topical Lidocaine 4% Cream was applied prior to intravenous cannulation.
110
Total224

Withdrawals & dropouts

PeriodReasonFG000FG001
Randomization and IV Placement AttemptUnsuccessful IV Access on First Attempt1413
Successful IV Placement & Follow-UpWithdrawal by Subject611

Baseline characteristics

CharacteristicBuzzy®Topical Lidocaine 4% CreamTotal
Age, Categorical
<=18 years
114 Participants110 Participants224 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Region of Enrollment
United States
114 participants110 participants224 participants
Sex: Female, Male
Female
53 Participants52 Participants105 Participants
Sex: Female, Male
Male
61 Participants58 Participants119 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1340 / 134
serious
Total, serious adverse events
0 / 1340 / 134

Outcome results

Primary

Change From Baseline in Faces Pain Scale Revised (FPS-R) at 30 Minutes After IV Cannulation

The Faces Pain Scale Revised (FPS-R) is numerical self-report measure of pain intensity developed for children to score the sensation of pain from 0-10. Pictures of 6 cartoon faces ranging from neutral expression of no pain (0) to very much pain (10).

Time frame: Baseline and 30 minutes

Population: Analysis population includes only subjects whose first intravenous (IV) cannulation attempt was successful.

ArmMeasureValue (MEAN)
Buzzy®Change From Baseline in Faces Pain Scale Revised (FPS-R) at 30 Minutes After IV Cannulation-3.544 units on a scale
Topical Lidocaine 4% CreamChange From Baseline in Faces Pain Scale Revised (FPS-R) at 30 Minutes After IV Cannulation-3.436 units on a scale
Secondary

Comparison of the Face, Legs, Activity, Cry, Consolability Scale (FLACC) Score Immediately After IV Cannulation Between Groups

The Face, Legs, Activity, Cry, Consolability scale or FLACC scale is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria, which are each assigned a score of 0, 1 or 2. The FLACC score was completed immediately after IV cannulation by a member of the clinical care team who was not part of the study. During initial trial design, the goal was to collect FLACC score pre and post cannulation; however, it was decided prior to enrollment that FLACC score would not be collected pre cannulation, only post.

Time frame: Up to 5 minutes after IV Cannulation

Population: Analysis population includes only subjects whose first intravenous (IV) cannulation attempt was successful.

ArmMeasureValue (MEDIAN)
Buzzy®Comparison of the Face, Legs, Activity, Cry, Consolability Scale (FLACC) Score Immediately After IV Cannulation Between Groups0.667 units on a scale
Topical Lidocaine 4% CreamComparison of the Face, Legs, Activity, Cry, Consolability Scale (FLACC) Score Immediately After IV Cannulation Between Groups0.333 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026